ATE270545T1 - Verwendung von nmda antagonisten zur behandlung des reizkolons - Google Patents
Verwendung von nmda antagonisten zur behandlung des reizkolonsInfo
- Publication number
- ATE270545T1 ATE270545T1 AT99947024T AT99947024T ATE270545T1 AT E270545 T1 ATE270545 T1 AT E270545T1 AT 99947024 T AT99947024 T AT 99947024T AT 99947024 T AT99947024 T AT 99947024T AT E270545 T1 ATE270545 T1 AT E270545T1
- Authority
- AT
- Austria
- Prior art keywords
- nmda antagonists
- irritable colon
- treat irritable
- treat
- colon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801494A SE9801494D0 (sv) | 1998-04-28 | 1998-04-28 | Novel use |
| SE9803954A SE9803954D0 (sv) | 1998-11-18 | 1998-11-18 | Novel use |
| PCT/SE1999/000702 WO1999055323A1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270545T1 true ATE270545T1 (de) | 2004-07-15 |
Family
ID=26663287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99947024T ATE270545T1 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda antagonisten zur behandlung des reizkolons |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1073431B1 (de) |
| JP (1) | JP2002512956A (de) |
| KR (1) | KR100569777B1 (de) |
| CN (1) | CN1200702C (de) |
| AR (1) | AR016212A1 (de) |
| AT (1) | ATE270545T1 (de) |
| AU (1) | AU760783B2 (de) |
| BR (1) | BR9909971A (de) |
| CA (1) | CA2329328A1 (de) |
| DE (1) | DE69918541T2 (de) |
| DK (1) | DK1073431T3 (de) |
| ES (1) | ES2221753T3 (de) |
| HK (1) | HK1033876A1 (de) |
| IL (1) | IL138919A0 (de) |
| MY (1) | MY121063A (de) |
| NO (1) | NO20005386L (de) |
| NZ (1) | NZ507436A (de) |
| PT (1) | PT1073431E (de) |
| SA (1) | SA99200482B1 (de) |
| TW (1) | TW570793B (de) |
| WO (1) | WO1999055323A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001064202A2 (en) * | 2000-03-01 | 2001-09-07 | Euro-Celtique S.A. | Tramadol for the treatment of functional gastrointestinal disorders |
| TW593223B (en) * | 2000-06-20 | 2004-06-21 | Merz Pharma Gmbh & Co Kgaa | 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| JP2003081872A (ja) * | 2001-09-13 | 2003-03-19 | Nippon Oruganon Kk | 掻痒治療薬 |
| PT1603544E (pt) * | 2003-03-14 | 2008-01-22 | Agi Therapeutics Res Ltd | Tratamento de problemas intestinais com n-2,3,3-tetrametilbiciclo 2.2.2. heptan-2-amina |
| WO2004084889A1 (en) * | 2003-03-28 | 2004-10-07 | Pfizer Inc. | Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons |
| FR2865133B1 (fr) * | 2004-01-19 | 2008-01-18 | Rytek | Compositions pour le traitement de pathologies digestives |
| EP3817746A4 (de) * | 2018-07-06 | 2022-04-06 | Algernon Pharmaceuticals Inc. | Verbindungen zur behandlung von entzündlichen darmerkrankungen und verfahren dafür |
| KR102211282B1 (ko) | 2019-11-20 | 2021-02-03 | (주)파이브텍 | 데이터 라우팅 방법 및 이를 지원하는 스위치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84305A (en) * | 1987-02-06 | 1992-01-15 | Fisons Corp | 2-aminoacetamide derivatives |
| GB9518027D0 (en) * | 1995-09-05 | 1995-11-08 | Wellcome Found | Pharmacologically active compound |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
-
1999
- 1999-04-20 AR ARP990101817A patent/AR016212A1/es unknown
- 1999-04-27 MY MYPI99001635A patent/MY121063A/en unknown
- 1999-04-28 ES ES99947024T patent/ES2221753T3/es not_active Expired - Lifetime
- 1999-04-28 WO PCT/SE1999/000702 patent/WO1999055323A1/en active IP Right Grant
- 1999-04-28 NZ NZ507436A patent/NZ507436A/en unknown
- 1999-04-28 PT PT99947024T patent/PT1073431E/pt unknown
- 1999-04-28 JP JP2000545522A patent/JP2002512956A/ja active Pending
- 1999-04-28 AT AT99947024T patent/ATE270545T1/de not_active IP Right Cessation
- 1999-04-28 AU AU43024/99A patent/AU760783B2/en not_active Ceased
- 1999-04-28 DE DE69918541T patent/DE69918541T2/de not_active Expired - Fee Related
- 1999-04-28 EP EP99947024A patent/EP1073431B1/de not_active Expired - Lifetime
- 1999-04-28 IL IL13891999A patent/IL138919A0/xx not_active IP Right Cessation
- 1999-04-28 CN CNB998078182A patent/CN1200702C/zh not_active Expired - Fee Related
- 1999-04-28 CA CA002329328A patent/CA2329328A1/en not_active Abandoned
- 1999-04-28 DK DK99947024T patent/DK1073431T3/da active
- 1999-04-28 KR KR1020007011958A patent/KR100569777B1/ko not_active IP Right Cessation
- 1999-04-28 BR BR9909971-3A patent/BR9909971A/pt not_active Application Discontinuation
- 1999-08-13 TW TW088113888A patent/TW570793B/zh active
- 1999-08-17 SA SA99200482A patent/SA99200482B1/ar unknown
-
2000
- 2000-10-26 NO NO20005386A patent/NO20005386L/no not_active Application Discontinuation
-
2001
- 2001-06-27 HK HK01104450A patent/HK1033876A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005386D0 (no) | 2000-10-26 |
| KR100569777B1 (ko) | 2006-04-11 |
| AR016212A1 (es) | 2001-06-20 |
| WO1999055323A1 (en) | 1999-11-04 |
| NO20005386L (no) | 2000-10-26 |
| MY121063A (en) | 2005-12-30 |
| TW570793B (en) | 2004-01-11 |
| CN1200702C (zh) | 2005-05-11 |
| CN1307471A (zh) | 2001-08-08 |
| EP1073431B1 (de) | 2004-07-07 |
| DK1073431T3 (da) | 2004-10-04 |
| NZ507436A (en) | 2003-09-26 |
| KR20010043077A (ko) | 2001-05-25 |
| HK1033876A1 (en) | 2001-09-28 |
| EP1073431A1 (de) | 2001-02-07 |
| PT1073431E (pt) | 2004-10-29 |
| AU760783B2 (en) | 2003-05-22 |
| CA2329328A1 (en) | 1999-11-04 |
| SA99200482B1 (ar) | 2006-06-27 |
| IL138919A0 (en) | 2001-11-25 |
| DE69918541D1 (de) | 2004-08-12 |
| AU4302499A (en) | 1999-11-16 |
| BR9909971A (pt) | 2000-12-26 |
| JP2002512956A (ja) | 2002-05-08 |
| DE69918541T2 (de) | 2005-08-18 |
| ES2221753T3 (es) | 2005-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| DE69722681D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen | |
| ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| ATE401909T1 (de) | Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| DE69836915D1 (de) | Mundpflegemittel zur behandlung von übelriechendem atem | |
| ATE308364T1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE419856T1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| ATE247987T1 (de) | Behandlung zur beseitigung von gerüchen | |
| ATE323661T1 (de) | Behandlung von mineralischen stoffen | |
| ATE291427T1 (de) | Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms | |
| ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| ATE301703T1 (de) | Verwendung von zusammensetzungen zur textilpflege | |
| DE69625877D1 (de) | Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE339955T1 (de) | Verwendung von escitalopram zur behandlung von generalisierten angstzuständen | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| ATE270545T1 (de) | Verwendung von nmda antagonisten zur behandlung des reizkolons | |
| ATE410181T1 (de) | Verwendung von intereferon gamma zur behandlung von herzhypertrophie | |
| ATE326969T1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE261304T1 (de) | Verwendung von eletriptan zur vorbeugung des wiederauftretens der migräne | |
| DE69621447D1 (de) | Verwendung von nitroflavonoide zur behandlung von angstzuständen | |
| ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| ATE270102T1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE60103503D1 (de) | Verwendung von fsh zur behandlung von infertilität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1073431 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |